Latest / JACC Specialty Journals
JACC: CardioOncology Pulse - The PROACT Trial: Findings and Key Takeaways
JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.